Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland

Biochemical and Biophysical Research Communications

Volumn 270, Issue 1, 2000, Pages 298-302

  Kawabata, Atsufumi ^a   Morimoto, Nao ^a   Nishikawa, Hiroyuki ^b   Kuroda, Ryotaro ^a   Oda, Yasuo ^a   Kakehi, Kazuaki ^a  

^a KINKI UNIVERSITY   (Japan)

^b Fuso Pharmaceutical Industries Ltd   (Japan)

Author keywords

Mucin; Protease (proteinase) activated receptor; Sublingual gland; Trypsin

Indexed keywords

GENISTEIN; MUCIN; N ACETYLNEURAMINIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR; THROMBIN; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PAROTID GLAND; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND;

RICKETTSIA SP. PAR;

EID: 0034595060     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2404     Document Type: Article

References (24)

1. Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Proc. Natl. Acad. Sci. USA. 91:1994;9208-9212.
2. Kawabata A., Kuroda R. Jpn. J. Pharmacol. 1999.
3. Hollenberg M. D. Trends Pharmacol. Sci. 20:1999;271-273.
4. Hollenberg M. D., Saifeddine M., Al-Ani B., Kawabata A. Can. J. Physiol. Pharmacol. 75:1997;832-841.
5. Kawabata A., Saifeddine M., Al-Ani B., Leblond L., Hollenberg M. D. J. Pharmacol. Exp. Ther. 228:1999;358-370.
6. Al-Ani B., Saifeddine M., Kawabata A., Renaux B., Mokashi S., Hollenberg M. D. J. Pharmacol. Exp. Ther. 290:1999;753-760.
7. Cirino G., Cicala C., Bucci M. R., Sorrentino L., Maraganore J. M., Stone S. R. J. Exp. Med. 183:1996;821-827.
8. Kawabata A., Kuroda R., Minami T., Kataoka K., Taneda M. Br. J. Pharmacol. 125:1998;419-422.
9. Kawabata A., Kuroda R., Nishikawa H., Asai T., Kataoka K., Taneda M. Br. J. Pharmacol. 126:1999;1856-1862.
10. Vergnolle N., Hollenberg M. D., Wallace J. L. Br. J. Pharmacol. 126:1999;1262-1268.
11. Vergnolle N., Hollenberg M. D., Sharkey K. A., Wallace J. L. Br. J. Pharmacol. 127:1999;1083-1090.
12. Kawabata A., Kuroda R., Nishikawa H., Kawai K. Br. J. Pharmacol. 128:1999;865-872.
13. Kong W., McConalogue K., Khitin L. M., Hollenberg M. D., Payan D. G., Bohm S. K., Bunnett N. W. Proc. Natl. Acad. Sci. USA. 94:1997;8884-8889.
14. Nguyen T. D., Moody M. W., Steinhoff M., Okolo C., Koh D.-S., Bunnett N. W. J. Clin. Invest. 103:1999;261-269.
15. Kawabata A., Nishikawa H., Kuroda R., Kawai K. Jpn. J. Pharmacol. 79:1999;92P.
16. Hollenberg M. D., Saifeddine M., Al-Ani B. Mol. Pharmacol. 49:1996;229-233.
17. Slomiany B. L., Murty L. N., Piotrowski J., Slomiany A. Gen. Pharmacol. 27:1996;761-771.
18. Klein A., Diaz S., Ferreira I., Lamblin G., Roussel P., Manzi A. E. Glycobiology. 7:1997;421-432.
19. Zheng X.-L., Renaux B., Hollenberg M. D. J. Pharmacol. Exp. Ther. 285:1998;325-334.
20. Corvera C. U., Dery O., McConalogue K., Bohm S. K., Khitin L. K., Caughey G. H., Payan D. G., Bunnett N. W. J. Clin. Invest. 100:1997;1383-1393.
21. Nystedt S., Ramakrishnan V., Sundelin J. J. Biol. Chem. 271:1996;14910-14915.
22. Molino M., Barnathan E. S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J. A., Schechter N., Woolkalis M., Brass L. F. J. Biol. Chem. 272:1997;4043-4049.
23. Dery O., Corvera C. U., Steinhoff M., Bunnett N. W. Am. J. Physiol. 274:1998;C1429-C1452.
24. Purushotham K. R., Humphreys-Beher M. G. Crit. Rev. Oral Biol. Med. 6:1995;119-131.